Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mika Hirose

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
The Journal of Clinical Investigation|December 24, 2024
A conserved human CD4+ T cell subset recognizing the mycobacterial adjuvant trehalose monomycolateYuki Sakai, Minori Asa, Mika Hirose, et al.
Science Translational Medicine|August 30, 2023
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical modelsEmiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Cell|June 17, 2021
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodiesYafei Liu, Wai Tuck Soh, Jun-Ichi Kishikawa, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
The Journal of Clinical Investigation|December 24, 2024
A conserved human CD4+ T cell subset recognizing the mycobacterial adjuvant trehalose monomycolateYuki Sakai, Minori Asa, Mika Hirose, et al.
Science Translational Medicine|August 30, 2023
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical modelsEmiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Cell|June 17, 2021
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodiesYafei Liu, Wai Tuck Soh, Jun-Ichi Kishikawa, et al.
Pageof 5